Related Experiment Video
Updated: Jun 16, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Loss of protein kinase C delta gene expression in human squamous cell carcinomas: a laser capture microdissection
Vipin Yadav1, Nicole C Yanez, Sarah E Fenton
1Molecular Biology Program, Cardinal Bernardin Cancer Center, the Stritch School of Medicine, Department of Pathology, Room 304, Loyola University Medical Center, 2160 S First Avenue, Maywood, IL 60153, USA.
Abstract:
Protein kinase C delta (PKC-delta) protein levels are frequently low in chemically and UV-induced mouse skin tumors as well as in human cutaneous squamous cell carcinomas (SCCs). Furthermore, overexpression of PKC-delta in human SCC lines and mouse epidermis is sufficient to induce apoptosis and suppress tumorigenicity, making PKC-delta a potential tumor suppressor gene for SCCs. Here we report that PKC-delta is lost in human SCCs at the transcriptional level. We used laser capture microdissection to isolate cells from three normal human epidermis and 14 human SCCs with low PKC-delta protein. Analysis by quantitative reverse transcription-PCR revealed that PKC-delta RNA was reduced an average of 90% in the SCCs tested, consistent with PKC-delta down-regulation at the protein level. Analysis of DNA from nine of the same tumors revealed that PKC-delta gene was deleted in only one tumor. In addition, Ras-transformed human keratinocytes, which have selective down-regulation of PKC-delta at both protein and mRNA levels, had significantly repressed human PKC-delta promoter activity. Together, these results indicate that PKC-delta gene expression is suppressed in human SCCs, probably via transcription repression. Our results have implications for the development of topical therapeutic strategies to trigger the re-expression of pro-apoptotic PKC-delta to induce apoptosis in SCCs.
Insights
Protein kinase C delta (PKC-delta) is frequently lost in human squamous cell carcinomas (SCCs). This study shows PKC-delta gene expression is suppressed transcriptionally, suggesting a therapeutic target for SCCs.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Protein kinase C delta (PKC-delta) protein levels are reduced in mouse and human skin tumors.
- PKC-delta overexpression suppresses tumor growth, indicating its potential as a tumor suppressor gene.
Purpose of the Study:
- To investigate the mechanism of PKC-delta down-regulation in human cutaneous squamous cell carcinomas (SCCs).
- To explore therapeutic strategies targeting PKC-delta re-expression for SCC treatment.
Main Methods:
- Laser capture microdissection of normal epidermis and SCCs.
- Quantitative reverse transcription-PCR (qRT-PCR) to analyze PKC-delta RNA levels.
- DNA analysis to assess gene deletion.
- Reporter assays to evaluate PKC-delta promoter activity in Ras-transformed keratinocytes.
Main Results:
- PKC-delta RNA levels were reduced by an average of 90% in human SCCs.
- PKC-delta gene deletion was infrequent, observed in only one of nine tumors analyzed.
- Ras-transformed human keratinocytes showed repressed PKC-delta promoter activity, indicating transcriptional suppression.
Conclusions:
- PKC-delta gene expression is suppressed at the transcriptional level in human SCCs.
- The findings suggest that restoring PKC-delta expression could be a therapeutic strategy for SCCs.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
